← Back to Screener
Surgery Partners, Inc. Common Stock (SGRY)
Price$13.43
Favorite Metrics
Price vs S&P 500 (26W)-39.76%
Price vs S&P 500 (4W)1.14%
Market Capitalization$1.74B
All Metrics
P/CF (Annual)6.34x
Book Value / Share (Quarterly)$13.25
P/TBV (Annual)1.20x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.22%
Cash Flow / Share (Quarterly)$1.51
Price vs S&P 500 (YTD)-17.08%
Gross Margin (TTM)25.57%
Net Profit Margin (TTM)-2.22%
EPS (TTM)$-0.61
10-Day Avg Trading Volume1.14M
EPS Excl Extra (TTM)$-0.61
Revenue Growth (5Y)12.21%
EPS (Annual)$-0.61
ROI (Annual)-1.44%
Gross Margin (Annual)25.78%
Net Profit Margin (5Y Avg)-2.70%
Cash / Share (Quarterly)$1.86
Revenue Growth QoQ (YoY)2.38%
ROA (Last FY)-0.96%
Revenue Growth TTM (YoY)-20.14%
EBITD / Share (TTM)$4.27
ROE (5Y Avg)-4.76%
Operating Margin (TTM)11.41%
Cash Flow / Share (Annual)$1.51
P/B Ratio1.01x
P/B Ratio (Quarterly)1.17x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.09x
Net Interest Coverage (TTM)1.47x
ROA (TTM)-0.97%
EV / EBITDA (TTM)9.58x
EPS Incl Extra (Annual)$-0.61
Current Ratio (Annual)1.87x
Quick Ratio (Quarterly)1.65x
3-Month Avg Trading Volume1.64M
52-Week Price Return-37.99%
EV / Free Cash Flow (Annual)26.59x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$12.93
P/S Ratio (Annual)0.53x
Asset Turnover (Annual)0.41x
52-Week High$24.18
Operating Margin (5Y Avg)12.42%
EPS Excl Extra (Annual)$-0.61
CapEx CAGR (5Y)12.90%
Tangible BV CAGR (5Y)27.14%
26-Week Price Return-35.78%
Quick Ratio (Annual)1.65x
13-Week Price Return-18.80%
Total Debt / Equity (Annual)2.16x
Current Ratio (Quarterly)1.87x
Enterprise Value$5,200.408
Revenue / Share Growth (5Y)-7.36%
Asset Turnover (TTM)0.31x
Book Value / Share Growth (5Y)3.99%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)26.55x
Pretax Margin (Annual)3.53%
Cash / Share (Annual)$1.86
3-Month Return Std Dev46.98%
Gross Margin (5Y Avg)26.27%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)15.24%
EBITDA Interim CAGR (5Y)6.63%
ROE (Last FY)-4.55%
Net Interest Coverage (Annual)1.47x
EPS Basic Excl Extra (Annual)$-0.61
P/FCF (TTM)8.19x
Receivables Turnover (TTM)4.21x
EV / Free Cash Flow (TTM)26.59x
Total Debt / Equity (Quarterly)2.16x
EPS Incl Extra (TTM)$-0.61
Receivables Turnover (Annual)5.60x
ROI (TTM)-1.46%
P/S Ratio (TTM)0.70x
Pretax Margin (5Y Avg)4.23%
Revenue / Share (Annual)$26.01
Tangible BV / Share (Annual)$12.93
Forward P/E34.18x
Free OCF CAGR (5Y)-0.84%
Price vs S&P 500 (52W)-67.82%
Year-to-Date Return-14.43%
5-Day Price Return2.16%
EPS Normalized (Annual)$-0.61
ROA (5Y Avg)-1.05%
Net Profit Margin (Annual)-2.35%
Month-to-Date Return10.91%
Cash Flow / Share (TTM)$1.90
EBITD / Share (Annual)$4.27
Operating Margin (Annual)11.77%
LT Debt / Equity (Annual)1.58x
P/CF (TTM)6.34x
ROI (5Y Avg)-1.58%
LT Debt / Equity (Quarterly)1.58x
EPS Basic Excl Extra (TTM)$-0.61
P/TBV (Quarterly)1.20x
P/B Ratio (Annual)1.17x
Inventory Turnover (TTM)26.61x
Pretax Margin (TTM)3.46%
Book Value / Share (Annual)$13.25
Price vs S&P 500 (13W)-19.48%
Beta2.00x
P/FCF (Annual)8.89x
Revenue / Share (TTM)$19.43
ROE (TTM)-4.50%
52-Week Low$11.41
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.06
4.06
4.06
4.06
Industry Peers — Hospitals(5)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
SGRYSurgery Partners, Inc. Common Stock | — | -20.14% | 11.41% | -4.50% | $13.43 |
HCAHCA Healthcare, Inc. | 15.92x | 7.08% | 15.83% | 695.73% | $482.97 |
THCTenet Healthcare Corporation New | 11.86x | 3.12% | 16.44% | 34.82% | $192.00 |
UHSUniversal Health Services, Inc. Class B | 7.36x | 9.71% | 11.48% | 21.07% | $178.73 |
ARDTArdent Health, Inc. | 9.93x | 6.01% | 5.03% | 10.96% | $9.44 |
CYHCommunity Health Systems, Inc. | 0.85x | -1.19% | 12.70% | -48.03% | $3.13 |
About
Surgery Partners Inc operates an integrated platform of ambulatory surgical centers, surgical hospitals, anesthesia services, and physician practices. The company delivers surgical and ancillary healthcare services to patients and physicians while leveraging its vertically integrated model to optimize costs and clinical outcomes. It generates revenue through patient care service contracts across its network of operating facilities and medical providers.